The combination of enzalutamide and leuprolide significantly improves overall survival among patients with prostate cancer and a high risk for biochemical recurrence, according to a study published ...
Following the 2025 ESMO Congress, Dr. Joshua Saba sat down with Dr. Chandler Park to discuss recent advances in prostate cancer care.
According to the American Cancer Society, roughly 2 million new cancer cases are diagnosed each year. In 2024, Kendall Wingrove of Okemos became a member of the club that nobody wants to join. “When ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback